The formulation is stabilized using excipients such as citric acid, mannitol, and polysorbate 80, while an automated needle mechanism facilitates self-injection by extending and retracting the needle, thereby improving patient adherence and ease of use
This happens more often than most people admit
In a phase II study of the long-acting GLP-1RA efpeglenatide (4 mg once weekly, 6 mg once weekly, 6 mg once every 2 weeks, and 8 mg once every 2 weeks), patients with obesity and without diabetes had statistically significant reductions in body weight compared with placebo after 20 weeks of treatment (differences in least squares means were 6.3 to 7.2 kg
Step 4: Sustainable results Alongside significant weight loss, our members report improved mood, sleep, energy levels, and confidence